デフォルト表紙
市場調査レポート
商品コード
1481417

止血製品の世界市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別- 産業予測、2024年~2031年

Global Hemostasis Products Market Size, Share, Growth Analysis, By Product(Topical Hemostasis Products, Infusible Hemostasis Products), By Application(Trauma, Surgery), By End-user(Hospitals, Clinics) - Industry Forecast 2024-2031

出版日: | 発行: SkyQuest | ページ情報: 英文 219 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
止血製品の世界市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別- 産業予測、2024年~2031年
出版日: 2024年05月17日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

止血製品の世界市場規模は2022年に16億米ドルと評価され、2023年の16億9,000万米ドルから2031年には25億9,000万米ドルに成長し、予測期間(2024年~2031年)のCAGRは5.5%で成長する見通しです。

止血剤市場は、医療技術の向上と意識の高まりにより、世界規模で着実に拡大しています。これらの医薬品は、手術後や外傷後の止血だけでなく、さまざまな出血問題の管理にも不可欠です。止血剤市場は、人口の高齢化、慢性疾患の増加、手術件数の増加によって牽引されています。また、発展途上国におけるヘルスケア施設の利用しやすさも、業界の拡大を後押ししています。さらに、継続的な研究開発努力により、新しい止血製品が発売され、その有効性と安全性が高まっています。しかし、これらの製品は高価であり、規制上の障害もあるため、業界の拡大が阻まれる可能性があります。このような障害にもかかわらず、世界の止血材市場は、ヘルスケアの基準や技術が進歩するにつれて拡大すると予想されます。

目次

エグゼクティブサマリー

  • 市場概要
  • 運命の輪

調査手法

  • 情報調達
  • 二次データソースと一次データソース
  • 市場規模予測
  • 市場の危機と限界

親市場の分析

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題

主な市場の考察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料の分析
  • イノベーションマトリクス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主な投資の分析
  • 主な成功要因
  • 競合の程度

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • 規制情勢
  • ポーターの分析
  • 将来の混乱についての特別な考察

止血製品の世界市場:製品別

  • 市場概要
  • 局所止血製品
  • 輸液止血製品
  • 高度な止血製品

止血製品の世界市場:用途別

  • 市場概要
  • トラウマ
  • 手術
  • 血友病
  • 心筋梗塞

止血製品の世界市場:エンドユーザー別

  • 市場概要
  • 病院
  • クリニック
  • その他

止血製品の世界市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他のラテンアメリカ
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他の中東・アフリカ

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • Johnson & Johnson(US)
  • Pfizer(US)
  • Baxter International(US)
  • Medtronic(US)
  • B. Braun Melsungen AG(Germany)
  • Becton, Dickinson, and Company(BD)(US)
  • Tricol Biomedical(US)
  • Hemostasis LLC(US)
  • CuraMedical BV(Netherlands)
  • Teleflex Incorporated(US)
  • CryoLife, Inc.(US)
  • Ethicon, Inc.(US)
  • Grifols, S.A.(Spain)
  • Terumo Corporation(Japan)
  • Integra LifeSciences Holdings Corporation(US)
  • HemCon Medical Technologies, Inc.(US)
  • Zimmer Biomet Holdings, Inc.(US)
  • Haemonetics Corporation(US)
  • CSL Behring LLC(Australia)
  • Olympus Corporation(Japan)
目次
Product Code: SQMIG35A2702

Global Hemostasis Products Market size was valued at USD 1.60 billion in 2022 and is poised to grow from USD 1.69 billion in 2023 to USD 2.59 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2024-2031).

The market for hemostasis products is expanding steadily on a global scale as a result of rising awareness and improvements in medical technology. These medicines are essential for managing a variety of bleeding problems as well as for stopping bleeding after surgery and trauma cases. The market for hemostasis products is being driven by an aging population, an increase in chronic diseases, and an increase in surgeries. The growing accessibility of healthcare facilities in developing nations is also fostering industry expansion. In addition, continuous R&D endeavors are resulting in the launch of novel hemostasis products, augmenting their effectiveness and safety. The expensive cost of these items and regulatory obstacles, however, may prevent the industry from expanding. Notwithstanding these obstacles, the market for hemostasis products worldwide is expected to grow as healthcare standards and technologies advance.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemostasis Products Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hemostasis Products Market Segmental Analysis

The global hemostasis products market is segmented on the basis of product, application, end-user, and region. Based on product, the market is segmented as Topical Hemostasis Product, Infusible Hemostasis Products, and Advanced Hemostasis Products. On the basis of application, the market is segmented into Trauma, Surgery, Hemophilia, Myocardial Infarction. Based on the end-user, it is segregated into hospitals, clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Hemostasis Products Market

The treatment of bleeding problems and surgical operations are being significantly improved by innovations like the development of more environmentally friendly and safe hemostasis products, in addition to hemostatic agents and devices. These upgrades enhance patient outcomes and put pressure on a rise in the market.

Restraints in the Global Hemostasis Products Market

One of the most notable commercial constraints is the high price of hemostasis products. These products may be expensive, which limits their availability to patients in some areas and healthcare facilities with limited funding. The cost factor may prevent the widespread use of better hemostasis solutions, limiting their market penetration and possibly impairing patient care.

Market Trends of the Global Hemostasis Products Market

Both patients and healthcare organizations are looking for less intrusive ways to treat bleeding problems and surgical procedures. This movement makes use of the advancements in progressive hemostasis products and methods, which lessen tissue damage, speed up repair, and improve average patient outcomes. Due to its potential to improve patient comfort and reduce hospital stays, minimally invasive hemostasis techniques are gaining popularity. This trend is in line with the healthcare industry's emphasis on value-based treatment.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Hemostasis Products Market by Product

  • Market Overview
  • Topical Hemostasis Products
  • Infusible Hemostasis Products
  • Advanced Hemostasis Products

Global Hemostasis Products Market by Application

  • Market Overview
  • Trauma
  • Surgery
  • Hemophilia
  • Myocardial Infarction

Global Hemostasis Products Market by End-user

  • Market Overview
  • Hospitals
  • Clinics
  • and Others

Global Hemostasis Products Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Johnson & Johnson (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson, and Company (BD) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tricol Biomedical (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hemostasis LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CuraMedical BV (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CryoLife, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ethicon, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Grifols, S.A. (Spain)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences Holdings Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HemCon Medical Technologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zimmer Biomet Holdings, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Haemonetics Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CSL Behring LLC (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Olympus Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments